Motorcycle crashes are a substantial public health problem for children and teens. During 2003, among persons aged <19 years, at least 245 died and an estimated 56,870 were treated in U.S. hospital emergency departments (EDs) for injuries sustained while riding a motorcycle (1). National surveillance has focused primarily on monitoring and characterizing fatal and nonfatal injuries from motorcycle crashes occurring on public roads (2). However, during 2003, at least 13 motorcycle riders aged <19 years died in nontraffic incidents in places other than on public roads.* This report focuses on injuries associated with off-road motorcycle riding, an increasingly popular recreational activity among youths. To characterize nonfatal injuries among young off-road motorcycle riders in the United States, CDC analyzed data from the National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP) during [2001][2002][2003][2004]. Those data indicated that an estimated 23,800 off-road motorcyclists aged <19 years were treated for nonfatal injuries in U.S. hospital EDs each year. Programs and policies directed at reducing the number of injuries from off-road motorcycle riding need to be strengthened; requiring minimum ages for off-road motorcycle riding might help prevent such injuries among children and teens.
Motorcycle crashes are a substantial public health problem for children and teens. During 2003, among persons aged <19 years, at least 245 died and an estimated 56,870 were treated in U.S. hospital emergency departments (EDs) for injuries sustained while riding a motorcycle (1) . National surveillance has focused primarily on monitoring and characterizing fatal and nonfatal injuries from motorcycle crashes occurring on public roads (2) . However, during 2003, at least 13 motorcycle riders aged <19 years died in nontraffic incidents in places other than on public roads.* This report focuses on injuries associated with off-road motorcycle riding, an increasingly popular recreational activity among youths. To characterize nonfatal injuries among young off-road motorcycle riders in the United States, CDC analyzed data from the National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP) during [2001] [2002] [2003] [2004] . Those data indicated that an estimated 23,800 off-road motorcyclists aged <19 years were treated for nonfatal injuries in U.S. hospital EDs each year. Programs and policies directed at reducing the number of injuries from off-road motorcycle riding need to be strengthened; requiring minimum ages for off-road motorcycle riding might help prevent such injuries among children and teens.
Operated by the Consumer Product Safety Commission (CPSC), NEISS-AIP collects data regarding initial patient visits to U.S. EDs for all types and causes of injuries, approximately 500,000 each year (2) . NEISS-AIP data are drawn from a nationally representative subsample of 66 of 100 NEISS-AIP hospitals selected as a stratified probability sample of the estimated 5,400 hospitals with EDs in the United States and its territories. Data are weighted to represent the total number of initial injury-related visits each year in the United States, and estimates are adjusted for hospital nonresponse and changes in the number of ED visits from year to year.
For this study, NEISS-AIP cases of nonfatal injuries from off-road motorcycle riding were identified from narratives describing injury incidents that were abstracted from medical records and consumer product codes assigned by trained NEISS hospital coders. A motorcycle was defined as any road bike, dirt bike (or trail bike), moped, motor scooter, or minibike. Excluded were incidents involving three-wheeled and four-wheeled all-terrain vehicles (ATVs). Cases were defined as injuries among patients aged <19 years who were injured while riding off-road as the driver or passenger on a motorcycle; patients not riding on a motorcycle when injured (e.g., those injured while working on a motorcycle) were excluded. Cases were defined as off-road if the incident did not occur on a paved road or highway and the location of the incident was specified (e.g., woods, field, trail, backyard of home, or motocross arena). In addition, 20.4% of motorcycle injury incidents had no location specified and, therefore, were excluded from the study. Location was further classified as a motocross area if this was specified in the narrative or if the activity involved racing or jumping with motorcycles in an unspecified off-road location.
National estimates were based on weighted data for 1,319 cases in which patients aged <19 years were treated for offroad motorcyclist injuries at NEISS-AIP hospital EDs during * Treated in hospital emergency departments, on the basis of 1,319 cases reported by the National Electronic Injury Surveillance System-All Injury Program. † Might not sum to total because of rounding. § Per 100,000 population. ¶ Confidence interval. ** Estimates might be unstable because the coefficient of variation is >30% or the number of cases is <20. † † Motocross area includes motocross, race track, motorcycle park, or an unspecified off-road location if the activity involved racing or jumping with motorcycles. Other off-road area includes woods, field, trail, backyard of home, and other specified off-road locations. § § Includes persons who were observed, left against medical advice, or left before being examined. or the number of cases is <20. calculated using U.S. population estimates as denominators rather than the number of off-road motorcycle riders. Estimates of the number of these riders in the United States and the extent of their exposure (e.g., frequency and duration of riding) are not available. Finally, factors associated with offroad motorcycle riding injuries cannot be characterized more completely because no NEISS-AIP data were available on variables such as helmet use, motorcycle speed at the time of injury, alcohol use, or riding experience.
Off-road motorcycle riding, like operating motor vehicles on roadways, requires physical skills and judgment that children and young teens do not possess. In 2000, the American Academy of Pediatrics recommended that parents not allow children and teens aged <16 years to ride off-road motorcycles or ATVs and that states prohibit the use of such vehicles by children and teens in that age group (5) . Studies of ATV use indicate that state laws with age restrictions for off-road vehicle use can be effective in decreasing the proportion of riders under the minimum age and that requiring riders of off-road vehicles to wear helmets can reduce the risk for fatal injury (7, 8) . However, only 19 states require off-road motorcyclists aged <18 years to wear helmets, and only eight states † set minimum ages (range: 8-14 years) for operation of offroad motorcycles, according to the American Motorcycle Association (9) .
Health-care providers should counsel parents regarding the risks associated with children and teens riding any type of motorcycle and the benefits of helmet use (10) . This intervention and promotion of minimum age restrictions and helmet laws might help curtail the increase in off-road motorcycle injuries among children and teens.
Nonfatal Injuries and Restraint Use Among Child PassengersUnited States, 2004
During 1978-2004, annual rates of child fatalities from motor vehicle crashes (MVCs) declined from 31.8 to 22.3 deaths per million. This decline might be partially attributed to the increased use of both child safety seats (for infants and young children) and seatbelts (for older children) (1). Nevertheless, among child passengers aged <12 years in 2004, nearly 1,200 children died (1) , and an estimated 180,000 were injured and treated in U.S. hospital emergency departments (EDs) (2) . Recent studies suggest that MVC fatalities and injuries among infants and children can be reduced further by promoting and enforcing age-appropriate restraint use (3). The National Electronic Injury Surveillance System-All Injury Program (NEISS-AIP) provides data on all injuryrelated hospital ED visits (4) . For this report, NEISS-AIP was expanded to collect additional information about injuries and restraint use for child passengers aged <12 years involved in MVCs during 2004 and examined at 15 U.S. EDs. Of the children injured in MVCs, 45% were either not restrained or inappropriately restrained. Most inappropriate restraint use occurred among children aged 4-8 years who were placed prematurely in seatbelts. The percentage of unrestrained children who were hospitalized was three times that of restrained children. Restraint use for child passengers should be promoted vigorously and enforced because it can reduce their risks for multiple injuries and hospitalization from MVCs. NEISS-AIP, maintained by the Consumer Product Safety Commission (CPSC), is a nationwide, stratified probability sample of hospitals that provides information on injuryrelated ED visits (4). NEISS-AIP routinely collects data that include 1) demographic information; 2) injury information, including the injury event, location, intent, and mechanism; and 3) medical information abstracted from ED charts (i.e., principal diagnosis, primary affected body part, treatment date, and ED discharge disposition). Hospitals are divided into five strata, four based on size (i.e., reported annual numbers of ED visits) and one stratum consisting of children's hospitals. A stratified random sample of 15 hospitals (three per stratum) was selected for this study from among the 50 NEISS-AIP hospitals that provided patient identifiers to CPSC for follow-up interviews. For these selected hospitals, NEISS-AIP data were expanded for 2004 by 1) collecting information for up to five injury diagnoses and affected body parts from ED records for children aged <12 years injured in MVCs and 2) interviewing parents about their child's restraint use and crash circumstances. This study was conducted with the approval of CDC's Institutional Review Board.
Restraint use was classified as unrestrained or restrained. For restrained children, appropriateness of restraint type was based on age, weight, and parent-reported height using child passenger safety guidelines from the National Highway Traffic Safety Administration (NHTSA) (5) . The guidelines state that 1) children should remain in rear-facing infant seats until they weigh >20 pounds and are aged 1 year, at which point they may be placed in forward-facing child safety seats; 2) children weighing >40 pounds may be placed in booster seats until they are aged >9 years or >57 inches tall, at which point they may wear lap/shoulder belts; and 3) children should not be placed in lap belts only (i.e., without shoulder belts).
This analysis used children's weights recorded in ED charts when available (for 272 children) and parent-reported weights when chart-reported weights were missing (for 323 children); children's weights were not available from either source for 40 children. In addition, this analysis assumed that 69 children aged <8 years with missing heights were <57 inches tall, on the basis of growth charts for U.S. children (6) , which report that 97% of children aged 7 years are <52 inches tall. The missing heights for two children aged 8 years in lap/shoulder belts were kept as "missing."
For the 1,370 children aged <12 years seen for injuries attributed to motor vehicles at the 15 participating EDs, CPSC contacted 911 households (66%). Of these 911 households, 738 (81%) agreed to participate; 649 (88%) child passengers in MVCs were eligible for this study. Restraint use was unknown for 14 children (2%). A total of 635 children were known to be either restrained (n = 578) or unrestrained (n = 57) ( Table 1 ). Eight percent of children aged <3 years, 6% aged 4-6 years, 10% aged 7-8 years, and 11% of children aged >9 years were unrestrained. Restraint use was similar for boys and girls. Among children whose race/ethnicity was known, the percentages of unrestrained black and Hispanic children were at least six times those of non-Hispanic whites (12% and 14%, respectively, versus 2%). The percentage of children in trucks who were unrestrained was three times that of those riding in other types of vehicles (24% versus 8% on average for cars, sports-utility vehicles, and vans).
Eighty-one percent of children had a single-injury diagnosis, whereas 16%, 3%, and 0.8% had two, three, and four diagnoses, respectively. Eight percent of children required hospital admission. The percentage of unrestrained children with multiple diagnoses was nearly twice that of restrained children (30% versus 18%). The percentage of unrestrained children requiring hospitalization was almost three times that of restrained children (21% versus 7%). Appropriateness of restraint type could be determined for 573 of 578 restrained children; 342 (59%) were restrained appropriately, and 231 (40%) were restrained inappropriately ( Table 2 ). Appropriateness of restraint type was unknown for five children (1%) because of missing data. Of those inappropriately restrained, 177 (77%) were children aged 4-8 years who were inappropriately wearing seatbelts. Of these 177, a total of 139 (79%) were wearing lap/shoulder belts, and 38 (21%) were wearing lap belts only. Eighty-nine (61%) of the 147 children aged 4-6 years and 87 (86%) of the 101 children aged 7-8 years were placed prematurely in seatbelts. One child aged 8 years, who was tall enough to wear a seatbelt, was restrained inappropriately in a lap belt only.
Appropriateness of restraint type was similar for boys and girls. A higher percentage of both black and Hispanic children were inappropriately restrained, compared with nonHispanic whites (47% and 50%, respectively, versus 34%). A higher percentage of children in trucks were restrained inappropriately, compared with children in other vehicle types (48% versus 40% on average for cars, sports-utility vehicles, and vans).
Editorial Note:
The results of this study underscore the need for restraint use for child passengers, which can reduce their risks for multiple injuries and hospitalization in MVCs. The findings in this study also are consistent with previous studies reporting that young children who should be in booster seats are often placed in seatbelts, including lap/shoulder and lap belts (3, 7, 8) . Previous studies have indicated that young children are at increased risk for serious injury when placed in seatbelts prematurely (3, 8) . Likely mechanisms include 1) increased head excursion, resulting in its impact with the child's knees or the vehicle interior or 2) rapid "jackknife" bending about an improperly fitted seatbelt, which increases risks for intraabdominal and spinal cord injuries (injuries known collectively as "seatbelt syndrome") (8) .
The findings in this report are subject to at least five limitations. First, these findings rely, in part, on parental reports of crash circumstances and their children's restraint use, heights, and weights, which might be subject to social desirability bias, particularly for restraint use. Although some discrepancies were observed between chart-reported and parent-reported weights for the 257 children who had data from both sources, they were well-correlated (correlation coefficient = 0.96, p<0.0001). Second, certain children aged <8 years with missing heights might have actually been >57 inches tall, so this analysis might have assumed incorrectly that they were not tall enough for lap/shoulder belts. Third, crash circumstances were not verified independently or investigated. Fourth, generalizability of this study's findings might be limited by its low response rate, small sample size, and missing data for race/ethnicity. Finally, individual ED health-care providers might vary in how thoroughly they record diagnosis information.
Child restraint laws in all 50 states should be updated to be consistent with current NHTSA guidelines and vigorously enforced. Booster seat use should be promoted for children who have outgrown child safety seats but have not yet reached the appropriate age or height for wearing lap/shoulder belts. Although 33 states and the District of Columbia have laws (9) . Communitybased interventions to increase age-appropriate child restraint use should target groups with higher rates of nonuse of restraints (e.g., blacks, Hispanics, and truck passengers) and inappropriate restraint use (e.g., premature graduation to lap/ shoulder belts and use of lap belts only). Two of the national health objectives for 2010 include reduction in deaths from MVCs and increased restraint use for child passengers (10) . Child passenger safety also has been identified as a research priority by CDC, which conducts research, supports extramural research and programs, and disseminates information regarding safe practices.
Hantavirus Pulmonary SyndromeFive States, 2006
Hantavirus pulmonary syndrome (HPS) is a rodentborne viral disease characterized by severe pulmonary illness and a case-fatality ratio of 30%-40%. Sin Nombre virus causes the majority of HPS cases in the United States, and the deer mouse (Peromyscus maniculatus) is its predominant reservoir. This report describes an increase in human cases of HPS reported during January-March 2006 from Arizona, New Mexico, North Dakota, Texas, and Washington state. The findings emphasize the need for renewed attention to reducing the risk for hantavirus exposure.
Human HPS
HPS is characterized by a febrile illness (i.e., temperature >101.0 º F) associated with bilateral diffuse interstitial edema of the lungs developing within 72 hours of hospitalization in a previously healthy person; radiographically, the edema can resemble acute respiratory distress syndrome (1) . Annually, the majority of HPS cases occur in spring and summer; however, the seasonality of HPS can vary by elevation, location, and biome, and cases have been identified throughout the winter and early spring (2) . Since recognition of the disease in 1993, CDC has confirmed 438 cases of HPS* reported from 30 states among residents of 32 states ( Figure 1 ); 35% (154) of these cases were fatal.
During January-March 2006, a total of nine confirmed cases (based on onset date) of HPS were reported from Arizona, New Mexico, North Dakota, Texas, and Washington. Six of the nine cases were in Arizona and New Mexico. During 1994 and 1999, a similar number of HPS cases was confirmed nationally in the same 3-month period. Both years were characterized by environmental conditions (e.g., increased rainfall and vegetative biomass) during the preceding 1-2 years that promoted increased rodent populations. This, in turn, increased virus transmission in the rodent populations and increased exposure risk for humans (2) (3) (4) . During 1994, 1999, and 2000, more than six cases were confirmed in the first 3 months of each year, and all had a high yearly total of HPS cases ( Figure 2 ). Nine cases of HPS were identified in the first 3 months of 2006, suggesting that a greater risk for human hantavirus infection might exist this year. Editorial Note: Hantavirus infection can occur after exposure to infectious virus in rodent saliva or excreta. HPS typically begins as headache, fever, and myalgia and is soon followed by pulmonary edema, which often leads to severe respiratory compromise; thrombocytopenia, presence of immunoblasts, and hemoconcentration are characteristic laboratory findings (1). Other than supportive care, no treatment exists for hantavirus infection. The probability of surviving HPS increases with early recognition, hospitalization, and aggressive pulmonary and hemodynamic support (5, 6) . All health-care providers are strongly encouraged to become familiar with the signs and symptoms of HPS (7) and to report suspected cases immediately to their state health departments.
Since 1994, CDC has sponsored continuous monitoring of rodent populations at study sites in Arizona, Colorado, New Mexico, and Montana (8) . Larger rodent populations and subsequent higher prevalence of hantavirus infection in rodent populations have been associated with higher risk for hantavirus exposure in human populations (2,9,10). Environmental conditions, including increased rainfall during 2005, likely contributed to increased rodent populations in certain areas of the Southwest. Some rodent monitoring sites have continued to have high rodent population densities or high levels of hantavirus infection during spring 2006, suggesting an increased risk for hantavirus infection among human populations in certain rural areas (J Mills, PhD, personal communication, May 2006).
Public health education (especially among residents of rural areas of the western United States) regarding the importance of risk-reduction measures should be emphasized, especially in spring and summer, when the majority of previous HPS cases have been identified. Most persons with HPS are thought to have been infected in and around their homes; therefore, limiting opportunities for peridomestic exposure to rodents and their excreta is particularly important.
CDC's Seal Up! Trap Up! Clean Up! campaign offers detailed information on preventing transmission of diseases from rodents and a comprehensive rodent-control website. † Measures to prevent HPS include 1) sealing up holes inside and outside the home to prevent entry by rodents, 2) trapping rodents around the home to help reduce the rodent population, 3) cleaning up potential rodent food sources and nesting sites, and 4) taking precautions when cleaning. CDC also provides detailed recommendations for HPS risk reduction (10) . Additional information regarding HPS is available from local or state health departments; through the hantavirus hotline, 404-639-1510; on CDC's All About Hantaviruses website § ; and by mail. ¶ (3) 68 (3) 32 (1) 
Notice to Readers

Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) for the Control and Elimination of Mumps
On June 1, this notice was posted as an MMWR Early Release on the MMWR website (http://www.cdc.gov/mmwr).
On May 17, 2006, the Advisory Committee on Immunization Practices (ACIP) updated criteria for mumps immunity and mumps vaccination recommendations. According to the 1998 ACIP recommendations for measles, mumps, and rubella (MMR) vaccine, for routine vaccination, a first dose of MMR vaccine is recommended at ages 12-15 months and a second dose at ages 4-6 years. Two doses of MMR vaccine also are recommended for students attending colleges and other post-high school institutions (1). However, documentation of mumps immunity through vaccination has consisted of only 1 dose of mumps-containing vaccine for all designated groups, including health-care workers.
Live mumps virus vaccines (i.e., mumps and MMR vaccines) produced in the United States are derived from the Jeryl Lynn mumps vaccine strain. Postlicensure studies in the United States demonstrated that 1 dose of mumps vaccine was 78%-91% effective in preventing clinical mumps with parotitis (2). However, in the late 1980s and early 1990s, mumps outbreaks were observed in schools with extremely high (>95%) vaccination coverage (3, 4) , suggesting that 1 dose of mumps vaccine or MMR vaccine was not sufficient to prevent mumps outbreaks in school settings.
In response to the resurgence of measles that began in 1989 and continued through 1991 (1), a second dose of MMR vaccine for school-aged (i.e., grades K-12) and college students was recommended in 1989. Since implementation of the 2-dose MMR vaccination requirement, the incidence of mumps disease has decreased, and studies of vaccine effectiveness during outbreaks suggest substantially higher levels of protection with a second dose of MMR. For example, during a mumps outbreak at a Kansas high school during the 1988-89 school year, students who had received only 1 dose of MMR had five times the risk of contracting mumps compared with students who had received 2 doses (3). A study from the United Kingdom, which uses MMR vaccines that contain either the Jeryl Lynn mumps vaccine strain or the RIT 4385 strain (derived from the Jeryl Lynn strain) (2), indicated a vaccine effectiveness of 88% for 2 doses of MMR vaccine compared with 64% for a single dose (5) . In addition, elimination of mumps was declared in Finland through high and sustained coverage with 2 doses of MMR vaccine (6) .
Infection-control failures resulting in nosocomial transmission have occurred during mumps outbreaks involving hospitals and long-term-care facilities that housed adolescent and young adult patients (7) . Exposures to mumps in health-care settings also can result in added economic costs associated with furlough or reassignment of staff members from patientcare duties or closure of wards.
During January 1-May 2, 2006, the current outbreak in the United States has resulted in reports of 2,597 cases of mumps in 11 states (8) . The outbreak has underscored certain limitations in the 1998 recommendations relating to prevention of mumps transmission in health-care and other settings with high risk for mumps transmission. After reviewing data from the current outbreak and previous evidence on mumps vaccine effectiveness and transmission, ACIP issued updated recommendations for mumps vaccination (Box).
Acceptable Presumptive Evidence of Immunity to Mumps
Acceptable presumptive evidence of immunity to mumps includes one of the following: 1) documentation of adequate vaccination, 2) laboratory evidence of immunity, 3) birth before 1957, or 4) documentation of physician-diagnosed mumps. Evidence of immunity through documentation of adequate vaccination is now defined as 1 dose of a live mumps virus vaccine for preschool-aged children and adults not at high risk and 2 doses for school-aged children (i.e., grades K-12) and for adults at high risk (i.e., health-care workers,* * Health-care workers include persons who provide health care to patients or work in institutions that provide patient care (e.g., physicians, nurses, emergency medical personnel, dental professionals and students, medical and nursing students, laboratory technicians, hospital volunteers, or administrative and support staff in health-care institutions).
MMWR June 9, 2006
† The first dose of mumps-containing vaccine should be administered on or after the first birthday; the second dose should be administered no earlier than 1 month (i.e., at a minimum of 28 days) after the first dose. MMR vaccine generally should be used whenever any of its component vaccines are indicated. For children aged 12 months-12 years, combined measles, mumps, rubella, and varicella (MMRV) vaccine can be considered if varicella vaccination is also indicated.
international travelers, and students at post-high school educational institutions). †
Routine Vaccination for Health-Care Workers
All persons who work in health-care facilities should be immune to mumps. Adequate mumps vaccination for healthcare workers born during or after 1957 consists of 2 doses of a live mumps virus vaccine. Health-care workers with no history of mumps vaccination and no other evidence of immunity should receive 2 doses (at a minimum interval of 28 days between doses). Health-care workers who have received only 1 dose previously should receive a second dose. Because birth before 1957 is only presumptive evidence of immunity, healthcare facilities should consider recommending 1 dose of a live mumps virus vaccine for unvaccinated workers born before 1957 who do not have a history of physician-diagnosed mumps or laboratory evidence of mumps immunity.
Mumps Outbreak Control
Depending on the epidemiology of the outbreak (e.g., the age groups and/or institutions involved), a second dose of mumps vaccine should be considered for children aged 1-4 years and adults who have received 1 dose. In health-care settings, an effective routine MMR vaccination program for health-care workers is the best approach to prevent nosocomial transmission. During an outbreak, health-care facilities should strongly consider recommending 2 doses of a live mumps virus vaccine to unvaccinated workers born before 1957 who do not have evidence of mumps immunity.
These new recommendations for health-care workers are intended to offer increased protection during a recognized outbreak of mumps. However, reviewing health-care worker immune status for mumps and providing vaccine during an outbreak might be impractical or inefficient. Therefore, facilities might consider reviewing the immune status of healthcare workers routinely and providing appropriate vaccinations, including a second dose of mumps vaccine, in conjunction with routine annual disease-prevention measures such as influenza vaccination or tuberculin testing.
Errata: Vol. 55, No. 21
In the Notice to Readers, "Annual Conference on Assessment Initiative -August 15-17, 2006," in the second sentence of the second paragraph, the Internet address provided for online registration information is incorrect. The correct link is http:// www.signup4.net/public/ap.aspx?EID=ASSE10E.
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S. Atlantic
W.S. Central  -0  5  2  34  -2  31  22  38  Arkansas  -0  1  -2  -0  2  1  3  Louisiana  -0  0  -3  -0  1  -2  Oklahoma  -0  0  ---0  6  2  2  Texas†   -0  5  2  29  -1  29  19 31 8  3  18  91  31  4  4  12  82  88  Alaska  -0  1  -1  -0  2  8  2  California  8  2  18  91  24  2  3  10  57  72  Hawaii  N  0  0  N  N  -0  4  -4  Oregon†   -0  3  -6  1  0  2  6  3  Washington  -0  3  --1  0  5  11  7 American Samoa New England  1  1  5  21  40  1  0  2  17  14  2  30  83  501  490  Connecticut  -0  2  6  9  -0  2  2  1  -1  5  16  32  Maine  -0  1  3  2  -0  1  3  2  -1  5  21  15  Massachusetts  1  0  3  10  19  1  0  2  10  4  -23  43  355  371  New Hampshire  -0  2  2  6  -0  2  2  6  1  2  36  64  18  Rhode Island  -0  1  -2  -0  0  ---0 -1  7  39  25  -1  4  28  25  1  3  26  60  382  Washington  -0  25  22  19  -0  11  8  18  3  11  195  160  214 American Samoa 12  12  26  236  315  -0  2  1  1  10  34  140  571  703  Connecticut  3  3  13  54  67  -0  0  ---6  132  132  144  Maine  -1  5  29  28  N  0  0  N  N  -2  8  22  64  Massachusetts  6  4  17  120  182  -0  2  1  -2  19  41  334  382  New Hampshire  -0  3  5  4  -0  1  --5  2  12  39  60  Rhode Island  -0  4  1  10  -0  2  -1  2  0  17  32  19  Vermont†   3  1  7  27  24  -0  0  --1  1  10 -0  4  12  1  -0  0  ---1  7  34  17  California  -3  15  56  68  1  0  1  2  -72  81  292  1,312  1,338  Hawaii  -0  0  ---0  0  ---5  15  87  107  Oregon†   -0  1  2  1  -0  1  -1  -7  25  147  153  Washington  U  0  0  U  U  N  0  0  N  N  9  10  124  154  131 American Samoa -0  0  ---1  5  19  21  -3  32  230  138  Utah  -0  8  19  15  -0  1  2  6  22  10  55  505  319  Wyoming  1  0  3  24  18  -0  0  ---0  3 -0  3  ---0  2  --Connecticut  -0  2  ---0  1  --Maine  -0  0  ---0  0  --Massachusetts  -0  3  ---0 -0  3 2  2  --0  2 2  -3  Arkansas  -0  3  ---0  2  -1  Louisiana  -0  20  ---0  9  -2  Oklahoma  -0  6  ---0  3  --Texas§   -0  1 6  2  --0  1 
New England
U 0 0 U U U 0 0 U U U 0 2 U 1 C.N.M.I. U 0 0 U U U 0 0 U U U 0 0 U U Guam - 0 0 - - - 0 0 - - -N 0 0 N N American Samoa U 0 0 U U U 0 2 U 3 U 0 0 U U C.N.M.I. U 0 0 U U U 0 0 U U U 0 0 U U Guam - 0 0 - - - 0 3 - 9 - 0 0 - - Puerto Rico - 0 1 - - - 0 2 2 - N 0 0 N N U.S. Virgin Islands - 0 0 - - - 0 0 - - - 0 0 - - C.N.
W.S. Central
